Co-morbidities

Philippe Pibarot, Patrizio Lancellotti, Jose Luis Zamorano, et al

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 5m 18s (6 videos)

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Watch time: 1h 3m 37s (4 videos)

Giuseppe Rosano , David Quek , Felipe Martínez ,

John JV McMurray, Stefan Anker, , et al

Watch time: 1h 31m 11s (8 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 7h 25m 37s (31 videos)

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 18h 39m 44s (23 videos)
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray,

Watch time: 6m 48s
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)

Shelley Zieroth, , , et al

Watch time: 20m 16s (3 videos)

Ovidiu Chioncel , Sean P Collins , Andrew P Ambrosy , et al

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Silvio Inzucchi, Andrew JS Coats, Richard Hobbs, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Shelley Zieroth,

Watch time: 3m 59s (1 video)

Paul Kalra,

Watch time: 12m 41s (2 videos)

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 5m 18s (6 videos)

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 18h 39m 44s (23 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Watch time: 1h 3m 37s (4 videos)

Andrew JS Coats, Stefan Anker,

Watch time: 23h 16m 49s (126 videos)
Watch Now

Carlos Juanatey,

Watch time: 9m 50s
Watch Now

Stylianos Tzeis,

Watch time: 11m 57s
Watch Now

Yassir Javaid,

Watch time: 12m 6s
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray,

Watch time: 6m 48s

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Watch time: 25h 43m 9s (27 videos)
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann,

Watch time: 22m 15s

Shelley Zieroth, , , et al

Watch time: 20m 16s (3 videos)
Association Between AID/FID with Incident CV Disease and Mortality

Benedikt Schrage,

Watch time: 5m 31s
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)
The PRESERVED-HF Study

Mikhail Kosiborod,

Watch time: 12m 4s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 7h 25m 37s (31 videos)
ACC 2021: The DARE-19 Randomized Trial

Mikhail Kosiborod,

Watch time: 15m 45s
ACC 2021 Discussion: The LIFE Trial

Harriette Van Spall, Douglas L Mann,

Watch time: 11m 30s

Philippe Pibarot, Patrizio Lancellotti, Jose Luis Zamorano, et al

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

Andrew JS Coats, Harriette Van Spall, Faiez Zannad, et al

Watch time: 49m 1s (3 videos)

Media

HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell,

Watch time: 3m 56s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Silvio Inzucchi, Andrew JS Coats, Richard Hobbs, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Shelley Zieroth,

Watch time: 3m 59s (1 video)

Andrew JS Coats,

Watch time: 5m 51s (1 video)

Paul Kalra,

Watch time: 12m 41s (2 videos)

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 5m 18s (6 videos)

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 18h 39m 44s (23 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Watch time: 1h 3m 37s (4 videos)
HF 22: SCD Risk Protection for Newly Diagnosed HF Patients

José González-Costello,

Watch time: 2m 16s

Andrew JS Coats, Stefan Anker,

Watch time: 23h 16m 49s (126 videos)
Watch Now

Carlos Juanatey,

Watch time: 9m 50s
Watch Now

Stylianos Tzeis,

Watch time: 11m 57s
Watch Now

Yassir Javaid,

Watch time: 12m 6s
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray,

Watch time: 6m 48s

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Watch time: 25h 43m 9s (27 videos)
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann,

Watch time: 22m 15s

Shelley Zieroth, , , et al

Watch time: 20m 16s (3 videos)
Association Between AID/FID with Incident CV Disease and Mortality

Benedikt Schrage,

Watch time: 5m 31s

John JV McMurray, Stefan Anker, , et al

Watch time: 1h 31m 11s (8 videos)
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)
The PRESERVED-HF Study

Mikhail Kosiborod,

Watch time: 12m 4s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 7h 25m 37s (31 videos)

Articles

Pharmacy Challenges in Cardiac Care During COVID-19: Lessons Learnt

Andrew McRae

,

Published:

02 February 2023

Citation:

Cardiac Failure Review 2023;9:e03.

DOI:

https://doi.org/10.15420/cfr.2022.20
  • Views: Views 317
  • Downloads: Downloads 20
  • Read time: 10 Mins

Polypharmacy in Older People With Heart Failure

Maria Stefil

,

Matthew Dixon

,

Jameela Bahar

,

Schabnam Saied

,

Knievel Mashida

,

Olivia Heron

,

Eduard Shantsila

,

Lauren Walker

,

Asangaedem Akpan

,

Gregory YH Lip

,

Rajiv Sankaranarayanan

,

Published:

19 December 2022

Citation:

Cardiac Failure Review 2022;8:e34.

DOI:

https://doi.org/10.15420/cfr.2022.14
  • Views: Views 1130
  • Downloads: Downloads 60
  • Read time: 21 Mins

SGLT2i in HFpEF

Mauro Gori

,

Emilia D’Elia

,

Edoardo Sciatti

,

Michele Senni

,

Published:

08 July 2022

Citation:

Cardiac Failure Review 2022;8:e26.

DOI:

https://doi.org/10.15420/cfr.2022.04
  • Views: Views 2481
  • Downloads: Downloads 244
  • Citations: 2

Medical Treatment of HFrEF in the Elderly

Ivan Milinkovic

,

Marija Polovina

,

Andrew JS Coats

,

Giuseppe Rosano

,

Petar M Seferovic

,

Published:

09 May 2022

Citation:

Cardiac Failure Review 2022;8:e17.

DOI:

https://doi.org/10.15420/cfr.2021.14
  • Views: Views 2456
  • Downloads: Downloads 215